OKOh Youn Kim

Oh Youn Kim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Oh Youn Kim has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Yong Song Gho

    Department of Life Sciences, POSTECH, Pohang, 37673, Republic of Korea

    3 shared publications
  • Changjin Lee

    Department of Life Sciences Pohang University of Science and Technology (POSTECH) Pohang Republic of Korea

    1 shared publication
  • Hyun Taek Park

    Department of Life Sciences, Pohang University of Science and Technology, Pohang, 37673, Republic of Korea

    1 shared publication
  • Jaemin Lee

    Department of Life Sciences Pohang University of Science and Technology (POSTECH) Pohang Republic of Korea

    1 shared publication
  • Jaewook Lee

    Department of Life Sciences, Pohang University of Science and Technology, Pohang, 37673, Republic of Korea

    1 shared publication
  • Jaewook Lee

    Department of Mechanical and Manufacturing Engineering, University of Calgary, Calgary, Canada

    1 shared publication

Latest Publications

  • Open Access

    Extracellular vesicles from in vivo liver tissue accelerate recovery of liver necrosis induced by carbon tetrachloride

    by Jaemin Lee, Sae Rom Kim, Changjin Lee, Ye In Jun, Seoyoon Bae, Yae Jin Yoon, Oh Youn Kim, Yong Song Gho

    Extracellular vesicles (EVs) are nano‐sized vesicles composed of proteolipid bilayers carrying various molecular signatures of the cells. As mediators of intercellular communications, EVs have gained great attention as new therapeutic agents in the field of nanomedicine. Therefore, many studies have explored the roles of cell‐derived EVs isolated from cultured hepatocytes or stem cells as inducer of liver proliferation and regeneration under various pathological circumstances. However, study investigating the role of EVs directly isolated from liver tissue has not been performed. Herein, to understand the pathophysiological role and to investigate the therapeutic potential of in vivo liver EVs, we isolated EVs from both normal and carbon tetrachloride (CCl4)‐induced damaged in vivo liver tissues. The in vivo EVs purified from liver tissues display typical features of EVs including spherical morphology, nano‐size, and enrichment of tetraspanins. Interestingly, administration of both normal and damaged liver EVs significantly accelerated the recovery of liver tissue from CCl4‐induced hepatic necrosis. This restorative action was through the induction of hepatocyte growth factor at the site of the injury. These results suggest that not only normal liver EVs but also damaged liver EVs play important pathophysiological roles of maintaining homeostasis after tissue damage. Our study, therefore, provides new insight into potentially developing in vivo EV‐based therapeutics for preventing and treating liver diseases.


  • Top Cited Papers
    Open Access

    Bacterial outer membrane vesicles suppress tumor by interferon-γ-mediated antitumor response

    by Oh Youn Kim, Hyun Taek Park, Nhung Thi Hong Dinh, Seng Jin Choi, Jaewook Lee, Ji Hyun Kim, Seung-Woo Lee, Yong Song Gho

    Gram-negative bacteria actively secrete outer membrane vesicles, spherical nano-meter-sized proteolipids enriched with outer membrane proteins, to the surroundings. Outer membrane vesicles have gained wide interests as non-living complex vaccines or delivery vehicles. However, no study has used outer membrane vesicles in treating cancer thus far. Here we investigate the potential of bacterial outer membrane vesicles as therapeutic agents to treat cancer via immunotherapy. Our results show remarkable capability of bacterial outer membrane vesicles to effectively induce long-term antitumor immune responses that can fully eradicate established tumors without notable adverse effects. Moreover, systematically administered bacterial outer membrane vesicles specifically target and accumulate in the tumor tissue, and subsequently induce the production of antitumor cytokines CXCL10 and interferon-γ. This antitumor effect is interferon-γ dependent, as interferon-γ-deficient mice could not induce such outer membrane vesicle-mediated immune response. Together, our results herein demonstrate the potential of bacterial outer membrane vesicles as effective immunotherapeutic agent that can treat various cancers without apparent adverse effects.